Un frottis tous les trois ans permet de prévenir l'apparition du cancer du col de l'utérus. Mais des facteurs sociaux entrent en jeu et jouent sur le respect de cette recommandation.

A newly established company called Grail and spun out from Illumina promises to develop a “liquid biopsy” test suitable for asymptomatic cancer detection and general screening. While the necessary sensitivity may be ...

In clinical oncology, obtaining sequence data from tumour samples has become practical in terms of logistics, turnover time and costs. The major issue now is the interpretation of this sequence to define actionable targets, ...